<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02159521</url>
  </required_header>
  <id_info>
    <org_study_id>EKOS-11</org_study_id>
    <nct_id>NCT02159521</nct_id>
  </id_info>
  <brief_title>Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic Endovascular System</brief_title>
  <acronym>ACCESS PTS</acronym>
  <official_title>ACCelerated ThrombolySiS for Post-Thrombotic Syndrome Using EKOS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EKOS Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BTG International Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>EKOS Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of ultrasound accelerated thrombolysis using the EkoSonic®
      Endovascular System with standard infusion of thrombolytic drug for post-thrombotic syndrome
      and chronic venous occlusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is designed to evaluate the safety and efficacy of ultrasound accelerated
      thrombolysis using the EkoSonic® Endovascular System with standard infusion of a thrombolytic
      drug for PTS and chronic DVT. Clinical effectiveness will be evaluated using a standard
      measure of severity of post-thrombotic syndrome over a year.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 10, 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">December 30, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Villalta Score</measure>
    <time_frame>Baseline through 30 days</time_frame>
    <description>Clinical efficacy will be evaluated using the Villalta score at Baseline compared to 30 days Post-EkoSonic® Study Treatment Procedure.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">113</enrollment>
  <condition>Deep Vein Thrombosis</condition>
  <condition>Post-thrombotic Syndrome</condition>
  <arm_group>
    <arm_group_label>prospective, single-arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EkoSonic endovascular system in the treatment of chronic deep vein thrombosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EkoSonic Endovascular System</intervention_name>
    <description>ultrasound catheter directed thrombolysis</description>
    <arm_group_label>prospective, single-arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion criteria:

          1. Male or female ≥ 18 years of age and ≤ 75 years of age.

          2. Proximal DVT (iliac vein, common femoral vein, deep femoral vein, femoral vein) that
             was objectively diagnosed with duplex imaging and/or venography ≥ 6 months prior to
             study screening.

          3. Persistent chronic DVT causing restrictive flow, as confirmed by imaging, within 60
             days prior to the study procedure.

          4. Villalta score ≥8 for the affected limb within 30 days prior to the study procedure.

          5. Failed a minimum of 3 consecutive months of conservative treatment (therapeutic
             anticoagulation and compression stockings) according to the completed Adherence to
             Conservative Treatment Form.

        Key Exclusion Criteria:

          1. Treated with mechanical thrombectomy within 2 weeks of the study thrombolysis
             procedure.

          2. Treated with thrombolysis drugs within 48 hours of the study thrombolytic procedure.

          3. Life expectancy less than 1 year.

          4. Body Mass Index (BMI) &gt;40 kg/m2 or per Investigator's discretion subject is able
             tolerate the procedure and be compliant with post-procedure increased physical
             activity.

          5. No flow in popliteal vein on duplex imaging

          6. Isolated iliac vein only thrombus.

          7. Thrombus extending ≥ 3 cm into the inferior vena cava (IVC). If central venous
             occlusion, consider computed tomography (CT) or magnetic resonance venography (MRV).
             For subjects with bilateral DVT, it is recommended that central imaging be performed
             prior to treatment to evaluate the status of the IVC.

          8. Active bleeding, recent (&lt; 3 mo) gastrointestinal (GI) bleeding, active peptic ulcer,
             severe liver dysfunction, bleeding diathesis.

          9. Recent (&lt; 3 mo) internal eye surgery or hemorrhagic retinopathy; recent (&lt; 10 days)
             major surgery, cataract surgery, trauma, cardiopulmonary resuscitation (CPR),
             obstetrical delivery, or other invasive procedure.

         10. History of stroke or intracranial/intraspinal bleed, tumor, vascular malformation,
             aneurysm.

         11. Active cancer (metastatic, progressive, or treated within the last 6 months).
             Exception: subjects with non-melanoma primary skin cancers are eligible to participate
             in the study.

         12. Hemoglobin &lt; 9.0 mg/dl within 24 hours prior to the procedure

         13. International normalized ratio (INR) ≥ 1.5 ng/dl within 24 hours prior to the
             procedure

         14. Platelet count &lt; 100,000 cells/mm3 or &gt;700,000 cells/mm3 within 24 hours prior to the
             procedure.

         15. Creatinine outside the normal range for the treating institution and considered
             clinically significant by the Investigator.

         16. Uncontrolled hypertension, defined as systolic &gt; 175 mmHg and a diastolic &gt; 110 mmHg.

         17. Use of clopidogrel, ticlopidine, or other thienopyridine antiplatelet drug within 7
             days of the study procedure.

         18. In the judgment of the clinician, the subject is at high risk for catastrophic
             bleeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Garcia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wilmington DE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Breakthroughs</name>
      <address>
        <city>Darien</city>
        <state>Connecticut</state>
        <zip>06820</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiana Hospital</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Atlanta Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center of Central Georgia</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Louisville Research Foundation</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Medical Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHI Health St. Elizabeth</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Name Medical Center</name>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aultman Hospital</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fairfield Medical Center</name>
      <address>
        <city>Lancaster</city>
        <state>Ohio</state>
        <zip>43130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DFW Vascular Group/ Methodist Dallas Medical Ctr</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Sugar Land Hospital</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <zip>77479</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Alexandria Hospital</name>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <zip>22304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.chronicdvtstudy.com</url>
    <description>study website</description>
  </link>
  <link>
    <url>http://www.ekoscorp.com</url>
    <description>EKOS company website</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2014</study_first_submitted>
  <study_first_submitted_qc>June 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2014</study_first_posted>
  <last_update_submitted>March 17, 2017</last_update_submitted>
  <last_update_submitted_qc>March 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>deep vein thrombosis</keyword>
  <keyword>post-thrombotic syndrome</keyword>
  <keyword>chronic deep vein thrombosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Postthrombotic Syndrome</mesh_term>
    <mesh_term>Postphlebitic Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

